PET for drug development

被引：0

作者：

Halldin, C ^{[1
]}

Gulyás, B ^{[1
]}

Farde, L ^{[1
]}

机构：

[1] Karolinska Hosp, Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, S-17176 Stockholm, Sweden

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：95 / 109

页数：15

共 50 条

[1] PET IN DRUG DEVELOPMENT
Lammertsma, Adriaan A.
[J]. 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2012, : 910 - 910
[2] PET and drug research and development
Fowler, JS
Volkow, ND
Wang, GJ
Ding, YS
Dewey, SL
[J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (07) : 1154 - 1163
[3] Chaperoning drug development with PET
Weber, WA
[J]. JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (05) : 735 - 737
[4] PET IN NEUROSCIENCE AND DRUG DEVELOPMENT
Halldin, C.
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 10 - 11
[5] Drug development, radiolabelled drugs and PET
Vaalburg, W
Hendrikse, NH
de Vries, EFJ
[J]. ANNALS OF MEDICINE, 1999, 31 (06) : 432 - 437
[6] PET in neuroscience drug discovery and development
Hargreaves, R
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2650 - U2650
[7] Role of PET in therapeutic drug development
McCarthy, Timothy J.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[8] PET technology for drug development in psychiatry
Arakawa, Ryosuke
Takano, Akihiro
Halldin, Christer
[J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (02) : 114 - 121
[9] Quantification of SPECT and PET for Drug Development
Seo, Youngho
[J]. CURRENT RADIOPHARMACEUTICALS, 2008, 1 (01) : 17 - 21
[10] Translational PET neuroimaging and drug development
Halldin, Christer
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250